{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T19:43:55Z","timestamp":1791575035826,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.urolonc.2022.11.024","type":"journal-article","created":{"date-parts":[[2023,1,14]],"date-time":"2023-01-14T00:41:23Z","timestamp":1673656883000},"page":"113-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2997-500X","authenticated-orcid":false,"given":"Mario","family":"Ochoa-Arvizo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Garc\u00eda-Campa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla M.","family":"Santos-Santillana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis R.","family":"Garc\u00eda-Chairez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro D.","family":"Gonz\u00e1lez-Colmenero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rigoberto","family":"Pallares-M\u00e9ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Cervantes-Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiram H.","family":"Plata-Huerta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene-","family":"Rodriguez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Guti\u00e9rrez-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0001","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.eururo.2012.07.028","article-title":"Systematic review of perioperative and quality-of-life outcomes following surgical management of localised renal cancer","volume":"62","author":"MacLennan","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2022.11.024_bib0002","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ejca.2018.07.005","article-title":"Cancer incidence and mortality patterns in Europe: estimates for 40 countries and 25 major cancers in 2018","volume":"103","author":"Ferlay","year":"2018","journal-title":"Eur J Cancer"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0003","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0090-4295(03)00773-8","article-title":"Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology","volume":"62","author":"Scherr","year":"2003","journal-title":"Urology"},{"issue":"36","key":"10.1016\/j.urolonc.2022.11.024_bib0004","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.2018.79.2341","article-title":"Current management of small renal masses, including patient selection, renal tumor biopsy, active surveillance, and thermal ablation","volume":"36","author":"Sanchez","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.juro.2008.09.017","article-title":"Partial nephrectomy versus radical nephrectomy in patients with small renal tumors\u2013is there a difference in mortality and cardiovascular outcomes?","volume":"181","author":"Huang","year":"2009","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0006","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.juro.2011.05.054","article-title":"Increased risk of overall and cardiovascular mortality after radical nephrectomy for renal cell carcinoma 2 cm or less","volume":"186","author":"Kates","year":"2011","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0007","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.eururo.2012.03.051","article-title":"Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis","volume":"62","author":"Sun","year":"2012","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.024_bib0008","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.eururo.2015.01.005","article-title":"EAU guidelines on renal cell carcinoma: 2014 update","volume":"67","author":"Ljungberg","year":"2015","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0009","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2010.12.013","article-title":"A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma","volume":"59","author":"Van Poppel","year":"2011","journal-title":"Eur Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2022.11.024_bib0010","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.urolonc.2016.07.007","article-title":"Partial nephrectomy vs. radical nephrectomy for renal tumors: a meta-analysis of renal function and cardiovascular outcomes","volume":"34","author":"Wang","year":"2016","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.urolonc.2022.11.024_bib0011","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Ann Intern Med"},{"issue":"7","key":"10.1016\/j.urolonc.2022.11.024_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.urolonc.2022.11.024_bib0013","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1503\/cmaj.1031981","article-title":"Tips for learners of evidence-based medicine: 3. Measures of observer variability (kappa statistic)","volume":"171","author":"McGinn","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.urolonc.2022.11.024_bib0014","unstructured":"Wells G, Shea B, O'Connell D, et al: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2013, http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0015","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1464-410X.2009.08376.x","article-title":"Comparison of rates and risk factors for developing chronic renal insufficiency, proteinuria and metabolic acidosis after radical or partial nephrectomy","volume":"104","author":"Malcolm","year":"2009","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.024_bib0016","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.urology.2009.05.090","article-title":"Prognostic factors for chronic kidney disease after curative surgery in patients with small renal tumors","volume":"74","author":"Jeon","year":"2009","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.024_bib0017","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.11.087","article-title":"Elective partial nephrectomy in patients with clinical T1b renal tumors is associated with improved overall survival","volume":"76","author":"Weight","year":"2010","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0018","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3109\/00365599.2010.521186","article-title":"Comparison of radical and partial nephrectomy in terms of renal function: a retrospective cohort study","volume":"45","author":"S\u00fcer","year":"2011","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.024_bib0019","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.urology.2011.10.073","article-title":"Functional analysis of elective nephron-sparing surgery vs radical nephrectomy for renal tumors larger than 4 cm","volume":"79","author":"Roos","year":"2012","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.024_bib0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000339969","article-title":"Comparison of renal function after partial nephrectomy and radical nephrectomy for renal cell carcinoma","volume":"89","author":"Miyamoto","year":"2012","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0021","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.juro.2012.11.043","article-title":"Uric acid levels correlate with baseline renal function and high levels are a potent risk factor for postoperative chronic kidney disease in patients with renal cell carcinoma","volume":"189","author":"Jeon","year":"2013","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0022","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3109\/21681805.2013.783624","article-title":"Kidney function following partial or radical nephrectomy for renal cell carcinoma: a population-based study","volume":"47","author":"Mariusdottir","year":"2013","journal-title":"Scand J Urol"},{"issue":"12","key":"10.1016\/j.urolonc.2022.11.024_bib0023","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4111\/kju.2013.54.12.830","article-title":"Renal function following curative surgery for renal cell carcinoma: who is at risk for renal insufficiency?","volume":"54","author":"Kong","year":"2013","journal-title":"Korean J Urol"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0024","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s11255-013-0534-8","article-title":"Predictive factors for the development of chronic renal insufficiency after renal surgery: a multicenter study","volume":"46","author":"Choi","year":"2014","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urolonc.2022.11.024_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2369-15-181","article-title":"Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma","volume":"15","author":"Kim","year":"2014","journal-title":"BMC Nephrol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0026","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.urology.2015.07.046","article-title":"New chronic kidney disease and overall survival after nephrectomy for small renal cortical tumors","volume":"86","author":"Mashni","year":"2015","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0027","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/bju.12883","article-title":"Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD)","volume":"115","author":"Yap","year":"2015","journal-title":"BJU Int"},{"issue":"11","key":"10.1016\/j.urolonc.2022.11.024_bib0028","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1007\/s00345-015-1538-z","article-title":"Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis","volume":"33","author":"O'Malley","year":"2015","journal-title":"World J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.024_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0126965","article-title":"Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study","volume":"10","author":"Lin","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.024_bib0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.urology.2015.02.067","article-title":"Analysis of renal functional outcomes after radical or partial nephrectomy for renal masses \u22657 cm using the RENAL score","volume":"86","author":"Kopp","year":"2015","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.024_bib0031","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4143\/crt.2014.122","article-title":"Oncologic and functional outcomes after partial nephrectomy versus radical nephrectomy in T1b renal cell carcinoma: a multicenter, matched case-control study in Korean patients","volume":"48","author":"Jang","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0032","first-page":"39","article-title":"Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go","volume":"22","author":"Lai","year":"2016","journal-title":"Hong Kong Med J"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.024_bib0033","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3346\/jkms.2017.32.3.495","article-title":"Preserving renal function through partial nephrectomy depends on tumor complexity in T1b renal tumors","volume":"32","author":"Yoo","year":"2017","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0034","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.euf.2017.02.015","article-title":"Exploratory subgroup analyses of renal function and overall survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy","volume":"3","author":"Scosyrev","year":"2017","journal-title":"Eur Urol Focus"},{"issue":"43","key":"10.1016\/j.urolonc.2022.11.024_bib0035","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.3346\/jkms.2018.33.e277","article-title":"Partial versus radical nephrectomy for T1-T2 renal cell carcinoma in patients with chronic kidney disease stage III: a multiinstitutional analysis of kidney function and survival rate","volume":"33","author":"Chung","year":"2018","journal-title":"J Korean Med Sci"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0036","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.eururo.2018.08.028","article-title":"Radical versus partial nephrectomy for cT1 renal cell carcinoma","volume":"74","author":"Gershman","year":"2018","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0037","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1681\/ASN.2017020136","article-title":"Incident CKD after radical or partial nephrectomy","volume":"29","author":"Leppert","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.11.024_bib0038","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/jso.25037","article-title":"Predictors of new-onset chronic kidney disease in patients managed surgically for T1a renal cell carcinoma: an Australian population-based analysis","volume":"117","author":"Ahn","year":"2018","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0039","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00345-019-02665-2","article-title":"Partial versus radical nephrectomy in very elderly patients: a propensity score analysis of surgical, functional and oncologic outcomes (RESURGE project)","volume":"38","author":"Mir","year":"2020","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0040","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/bju.15064","article-title":"Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group","volume":"126","author":"Bradshaw","year":"2020","journal-title":"BJU Int"},{"issue":"12","key":"10.1016\/j.urolonc.2022.11.024_bib0041","doi-asserted-by":"crossref","first-page":"392","DOI":"10.5489\/cuaj.6343","article-title":"Long-term outcomes after radical or partial nephrectomy for T1a renal cell carcinoma: a population-based study","volume":"14","author":"Nayan","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.024_bib0042","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/bju.15200","article-title":"Elevated preoperative C-reactive protein is associated with renal functional decline and non-cancer mortality in surgically treated renal cell carcinoma: analysis from the International Marker Consortium for Renal Cancer (INMARC)","volume":"127","author":"Cotta","year":"2021","journal-title":"BJU Int"},{"issue":"9-10","key":"10.1016\/j.urolonc.2022.11.024_bib0043","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1159\/000509206","article-title":"Perioperative blood transfusion is a predictor of acute and chronic renal function deterioration after partial and radical nephrectomy for renal cell carcinoma","volume":"104","author":"M\u00fchlbauer","year":"2020","journal-title":"Urol Int"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.024_bib0044","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/21681805.2021.1948916","article-title":"Impact of comorbidities on acute kidney injury and renal function impairment after partial and radical tumor nephrectomy","volume":"55","author":"Wenzel","year":"2021","journal-title":"Scand J Urol"},{"issue":"7","key":"10.1016\/j.urolonc.2022.11.024_bib0045","doi-asserted-by":"crossref","first-page":"446","DOI":"10.4111\/kju.2014.55.7.446","article-title":"The type of nephrectomy has little effect on overall survival or cardiac events in patients of 70 years and older with localized clinical t1 stage renal masses","volume":"55","author":"Kyung","year":"2014","journal-title":"Korean J Urol"},{"issue":"9","key":"10.1016\/j.urolonc.2022.11.024_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163253","article-title":"Nephrectomy type was not associated with a subsequent risk of coronary heart disease: a population-based study","volume":"11","author":"Chung","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.urolonc.2022.11.024_bib0047","doi-asserted-by":"crossref","first-page":"660.e17","DOI":"10.1016\/j.urolonc.2017.06.057","article-title":"Increased use of antihypertensive medications after partial nephrectomy vs. radical nephrectomy","volume":"35","author":"Hutchinson","year":"2017","journal-title":"Urol Oncol"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.024_bib0048","first-page":"241","article-title":"Renal function after nephrectomy influences the risk of cardiovascular events","volume":"72","author":"Kambara","year":"2018","journal-title":"Acta Med Okayama"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.024_bib0049","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.euo.2019.02.006","article-title":"Hypertension and cardiovascular morbidity following surgery for kidney cancer","volume":"3","author":"Capitanio","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/JU.0000000000000171","article-title":"Association of partial versus radical nephrectomy with subsequent hypertension risk following renal tumor resection","volume":"202","author":"Shah","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2022.11.024_bib0051","article-title":"Cause-specific mortality among survivors from T1N0M0 renal cell carcinoma: a registry-based cohort study","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"issue":"16","key":"10.1016\/j.urolonc.2022.11.024_bib0052","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1002\/cncr.28141","article-title":"Overall survival advantage with partial nephrectomy: a bias of observational data?","volume":"119","author":"Shuch","year":"2013","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.024_bib0053","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.juro.2012.11.121","article-title":"Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease","volume":"189","author":"Lane","year":"2013","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2022.11.024_bib0054","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ki.2013.460","article-title":"Long-term risks for kidney donors","volume":"86","author":"Mj\u00f8en","year":"2014","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.urolonc.2022.11.024_bib0055","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1161\/HYPERTENSIONAHA.115.06608","article-title":"Cardiovascular effects of unilateral nephrectomy in living kidney donors","volume":"67","author":"Moody","year":"2016","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.urolonc.2022.11.024_bib0056","doi-asserted-by":"crossref","first-page":"337","DOI":"10.5489\/cuaj.6436","article-title":"Partial vs. radical nephrectomy and the risk of all-cause mortality, cardiovascular, and nephrological outcomes","volume":"14","author":"Breau","year":"2020","journal-title":"Can Urol Assoc J"},{"issue":"5","key":"10.1016\/j.urolonc.2022.11.024_bib0057","doi-asserted-by":"crossref","first-page":"e619","DOI":"10.1016\/j.clgc.2020.02.004","article-title":"Incidence and risk factors of hypertension following partial nephrectomy in patients with renal tumors: a cross-sectional study of postoperative home blood pressure and antihypertensive medications","volume":"18","author":"Fukushima","year":"2020","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2022.11.024_bib0058","doi-asserted-by":"crossref","first-page":"F439","DOI":"10.1152\/ajprenal.00252.2013","article-title":"Renal and cardiovascular sensory receptors and blood pressure regulation","volume":"305","author":"Pluznick","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.urolonc.2022.11.024_bib0059","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/CIRCRESAHA.116.303587","article-title":"Hypertension: renin-angiotensin-aldosterone system alterations","volume":"116","author":"Te Riet","year":"2015","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.urolonc.2022.11.024_bib0060","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1523-1755.2005.00508.x","article-title":"Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis","volume":"68","author":"Vanegas","year":"2005","journal-title":"Kidney Int"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004847?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143922004847?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T03:50:25Z","timestamp":1741578625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143922004847"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1078143922004847"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.024","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal functional and cardiovascular outcomes of partial nephrectomy versus radical nephrectomy for renal tumors: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2022.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}